Enveric Biosciences Reports Financial Results for Third Quarter 2026 and Provides Corporate Update
CAMBRIDGE, Mass., November 13, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to addressโฆ




